Aclaris Therapeutics, Inc. (ACRS) has recently emerged as a penny stock that is gaining traction among investors.
Stifel, a prominent financial services firm, has expressed a bullish stance on Aclaris, highlighting its potential in the market.
As investors look for promising opportunities, Aclaris may be worth considering for those interested in penny stocks.